-
Pharmacy: Resident pharmacists cannot be replaced
Time of Update: 2020-08-23
in accordance with the relevant provisions, Retail pharmacies in Jiangxi Province to apply for the practice pharmacist remote review party, need to meet the following requirements: 1, to carry out the pilot drug business enterprises should have the corresponding quality management system and facilities and equipment.
-
Progesterone and lipoline receptor 3 (PAQR3) regulates the mechanism of liver lipid metabolism
Time of Update: 2020-08-14
Recently, the Chinese Academy of Sciences Shanghai Institute of Life Sciences (population health field) Chen Wei research group found that progesterone and lipoline receptor 3 (PAQR3) by promoting PPAR alpha ubiquitin and protease pathway dependence degradation, and thus regulate the mechanism of liver lipid metabolism.
-
To buy nutritional supplements for your child depends on these six points, Kenweile safety is more secure
Time of Update: 2020-08-13
Jianweile in line with the standard certification, full yqualification, ordinary products are mostly small workshop production, health is not known, the source of unknown or inspection fraud, without national testing certification.
-
Blackstone Mainland's first single flower fell blue star group
Time of Update: 2020-07-30
. at the same time, "Blue Star Group's overall listing plan has also entered the actual stage, intermediaries have also entered the market, and assets to map out." The overall listing will be broadly divided into three steps, the people said.
-
Under the normalization of collection, the price war on generic drugs opened
Time of Update: 2020-06-05
Pharmaceutical Network Industry Dynamic ) Recently, the Hebei Provincial Health Insurance Bureau issued the Notice on FurtherIng the Work of Drug Hanging Network (Draft for Comments), announcing tha
-
FDA aims to reduce drug costs A new program will be unveiled
Time of Update: 2020-05-31
Today, President Trump, along with the U.S Department of Health and Human Services and the U.S Food and Drug Administration (FDA), issued a proposed rule-making notice The proposal is intended to dete
-
Breakthrough therapy mobocertinib synthesis process analysis
Time of Update: 2020-05-30
On April 27, 2020, the FDA awarded mobocertinib (TAK-788) breakthrough therapy, not only to advance after platinum chemotherapy, EGFR exon 20 insertion of mutant non-small cell lung cancer patients wi
-
Another indication of pajite (R), an innovative breast cancer targeting drug owned by Roche, was approved in China
Time of Update: 2019-12-11
December 10, 2019 / AP / -- Roche pharmaceutical China announced on December 10 that China's National Drug Administration (nmpa) officially approved the first-line standard treatment plan of pajite ®
-
[Yao Kejun] who is the first to imitate the hottest global antithrombotic drug of 40 billion level? Who is the winner of Zhengda Tianqing, Huahai, Yangzi River and Ouyi? Changsheng was cancelled
Time of Update: 2019-05-20
New trends of review and approval this week (may 10-may 17), a total of 28 acceptance numbers of drugs reported for production are updated dynamically, including 3 acceptance numbers (3 varieties) for
-
The list of the first batch of A-share "entering the motorcycle" announced that 18 medical and health enterprises including Hengrui pharmaceutical are listed
Time of Update: 2018-05-15
Source: in the early morning of May 15, 2018, MSCI announced its semi-annual index adjustment results and officially admitted China's a shares into the MSCI Emerging Market Index, which is known in th
-
The debt of public hospitals in China exceeds 200 billion
Time of Update: 2015-12-28
Source: Daily Economic News December 28, 2015: the hospital with overcrowded patients is in high debt?
